This topic contains a solution. Click here to go to the answer

Author Question: Which antirejection drug belongs to the antiproliferative class? a. Basiliximab (Simulect) b. ... (Read 36 times)

deesands

  • Hero Member
  • *****
  • Posts: 514
Which antirejection drug belongs to the antiproliferative class?
 
  a. Basiliximab (Simulect)
  b. Cyclosporine (Neoral)
  c. Mycophenylate (CellCept)
  d. Tacrolimus (Prograf)

Question 2

Which exposure situation can lead to the development of naturally acquired immunity?
 
  a. Receiving seasonal influenza vaccination every year
  b. Taking a dose of oral polio vaccine
  c. Breastfeeding an infant
  d. Catching a cold



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Sophiapenny

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

ANS: C

Answer to Question 2

ANS: D




deesands

  • Member
  • Posts: 514
Reply 2 on: Jul 23, 2018
Thanks for the timely response, appreciate it


ttt030911

  • Member
  • Posts: 315
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Blood in the urine can be a sign of a kidney stone, glomerulonephritis, or other kidney problems.

Did you know?

There are more nerve cells in one human brain than there are stars in the Milky Way.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

Congestive heart failure is a serious disorder that carries a reduced life expectancy. Heart failure is usually a chronic illness, and it may worsen with infection or other physical stressors.

For a complete list of videos, visit our video library